"Designing Growth Strategies is in our DNA"

Generative AI in Life Sciences Market Size, Share & Industry Analysis, By Component (Software/Platforms and Services), By Deployment (Cloud-Based, On-Premise, and Hybrid), By Technology (Large Language Models (LLMs), Natural Language Processing (NLP), Generative Molecular/Protein Models, and Others), By Product Type (Standalone and Integrated), By Application (Drug Discovery & Design, Clinical Trial Design & Operations, and Others), By End User (Pharmaceutical & Biotechnology Companies, CROs, Academic & Research Institutes, and Others) and Regional Forecast, 2026-2034

Last Updated: June 19, 2026 | Format: PDF | Report ID: FBI117572

 


To get information on various segments, share your queries with us

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 35.52% from 2026 to 2034
Unit Value (USD Billion)
Segmentation  By Component, Deployment, Technology, Product Type, Application, End User, and Region
By Component
  • Software/Platforms
  • Services
By Deployment
  • Cloud-Based
  • On-Premise
  • Hybrid
By Technology
  • Large Language Models (LLMs)
  • Natural Language Processing (NLP)
  • Generative Molecular/Protein Models
  • Machine Learning & Deep Learning
  • Others
By Product Type
  • Standalone
  • Integrated
By Application
  • Drug Discovery & Design
  • Clinical Trial Design & Operations
  • Regulatory Writing & Submissions
  • Medical Affairs & Scientific Content
  • Pharmacovigilance
  • Commercial & Market Access Content
  • Others
By  End User
  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Academic & Research Institutes
  • MedTech/Diagnostics Companies
  • Others
By Region 
  • North America (By Component, Deployment, Technology, Product Type, Application, End User, and Country)
    • U.S. 
    • Canada
  • Europe (By Component, Deployment, Technology, Product Type, Application, End User, and Country/Sub-region)
    • Germany 
    • U.K.
    • France 
    • Spain 
    • Italy 
    • Scandinavia  
    • Rest of Europe
  • Asia Pacific (By Component, Deployment, Technology, Product Type, Application, End User, and Country/Sub-region)
    • China 
    • Japan 
    • India 
    • Australia 
    • Southeast Asia 
    • Rest of Asia Pacific 
  • Latin America (By Component, Deployment, Technology, Product Type, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Component, Deployment, Technology, Product Type, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

 

  • 2021-2034
  • 2025
  • 2021-2024
  • 190
Download Free Sample

    man icon
    Mail icon

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann